Rafiq Islam is the Regional Vice President for the Pharmaceutical Development Services division responsible for scientific and operational leadership
of bioanalytical operations in Gaithersburg, MD
and Ewing, NJ. Prior to joining Smithers, he was
the Executive Director of small and large molecule bioanalytical services at Celerion Inc. He also serves
as the chairman of the scientific advisory board for Somru Bioscience Inc. With over 20 years of biotechnology and CRO industry experience,
Mr. Rafiq has authored and contributed to more
than 50 articles, industry whitepapers, and
numerous posters on the topic of regulated bioanalysis, biomarker, immunogenicity and biosimilars.
Heather Baird Tomlinson is the Director for the
Global Clinical Diagnostics Strategic Business Unit at Promega Corporation bringing with her over a
decade of experience in the clinical diagnostics
market. Heather is responsible for the clinical
market segment at Promega, effectively leading
the team that drives the commercial strategy. Heather’s recent work focuses on microsatellite instability testing as a diagnostic test for predicting patient outcome to immune-oncology drugs. Heather has presented scientific evidence of the importance of MSI testing internationally, including in the United States, Europe, Asia, and Africa. Heather received her PhD in Pharmacology from Case Western University, and
her BS in Biochemistry from Ohio University.
Kevin Kohlmeier, Bachelor’s Degree
in Biochemistry from the University of
Washington. Kevin started his career on the lab
bench working on crystallization of
recombinant bacterial proteins. Since that time
he has worked with several products in the
vaccine space, starting with InDevR in 2010. He
has worked as Product Manager for the
VaxArray Product line since 2017.